
Kairos Pharma Announces 1-for-7 Reverse Stock Split for NYSE Compliance
Kairos Pharma has announced a 1-for-7 reverse stock split, a corporate action taken to increase its share price and maintain compliance with NYSE listing requirements.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
Coverage Timeline
Related Stories
TWG Global Denies Fraud Allegations Amid Ongoing Federal Investigation
19m ago

Bill Gates Warns of Unprepared World as He Proposes New AI Safeguards
23m ago
U.S. inflation rises again and stays well above Fed’s target. Rate hike might be in play.
24m ago

US Core Inflation Holds at 3.3% in July Amid Persistent Energy Costs
28m ago